

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | leukocyte aggregation (GO:0070486) | 6.41638896 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 6.27695171 |
| 3 | leukocyte migration involved in inflammatory response (GO:0002523) | 6.13501685 |
| 4 | detection of other organism (GO:0098543) | 6.09758941 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.09327815 |
| 6 | negative regulation of cell killing (GO:0031342) | 6.09327815 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.09172668 |
| 8 | detection of bacterium (GO:0016045) | 5.99362167 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.81299462 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.81299462 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 5.81299462 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 5.81299462 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 5.81299462 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.81299462 |
| 15 | response to peptidoglycan (GO:0032494) | 5.38831826 |
| 16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.35409231 |
| 17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.27890907 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.24902430 |
| 19 | detection of external biotic stimulus (GO:0098581) | 4.99049371 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 4.90334621 |
| 21 | neutrophil activation (GO:0042119) | 4.77667373 |
| 22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.75373763 |
| 23 | cellular extravasation (GO:0045123) | 4.69978670 |
| 24 | respiratory burst (GO:0045730) | 4.59145321 |
| 25 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.51617144 |
| 26 | negative regulation of interleukin-12 production (GO:0032695) | 4.43662198 |
| 27 | granulocyte activation (GO:0036230) | 4.38035351 |
| 28 | detection of biotic stimulus (GO:0009595) | 4.34786608 |
| 29 | detection of molecule of bacterial origin (GO:0032490) | 4.33907692 |
| 30 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.26507924 |
| 31 | regulation of mast cell degranulation (GO:0043304) | 4.14978056 |
| 32 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.12835072 |
| 33 | response to host immune response (GO:0052572) | 4.12835072 |
| 34 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.12551637 |
| 35 | immunoglobulin mediated immune response (GO:0016064) | 4.11053233 |
| 36 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.10129422 |
| 37 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.94334130 |
| 38 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.88343521 |
| 39 | microglial cell activation (GO:0001774) | 3.85101864 |
| 40 | defense response to fungus (GO:0050832) | 3.84723172 |
| 41 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.83419593 |
| 42 | myeloid cell activation involved in immune response (GO:0002275) | 3.83113458 |
| 43 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.79382356 |
| 44 | response to host (GO:0075136) | 3.78911262 |
| 45 | response to host defenses (GO:0052200) | 3.78911262 |
| 46 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.78911262 |
| 47 | regulation of gamma-delta T cell activation (GO:0046643) | 3.75682726 |
| 48 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.74684132 |
| 49 | positive regulation of mast cell activation (GO:0033005) | 3.74296121 |
| 50 | response to interleukin-15 (GO:0070672) | 3.70461156 |
| 51 | regulation of leukocyte degranulation (GO:0043300) | 3.67103011 |
| 52 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.63574917 |
| 53 | macrophage activation (GO:0042116) | 3.63370958 |
| 54 | neutrophil chemotaxis (GO:0030593) | 3.57612436 |
| 55 | regulation of mast cell activation (GO:0033003) | 3.57278698 |
| 56 | neutrophil mediated immunity (GO:0002446) | 3.56042352 |
| 57 | neutrophil migration (GO:1990266) | 3.48721227 |
| 58 | negative regulation of T cell mediated immunity (GO:0002710) | 3.48230182 |
| 59 | leukocyte degranulation (GO:0043299) | 3.46017931 |
| 60 | response to fungus (GO:0009620) | 3.38871349 |
| 61 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.37798810 |
| 62 | positive regulation of mast cell degranulation (GO:0043306) | 3.37798810 |
| 63 | mast cell activation (GO:0045576) | 3.30448148 |
| 64 | negative regulation of phagocytosis (GO:0050765) | 3.29841501 |
| 65 | regulation of regulated secretory pathway (GO:1903305) | 3.26953102 |
| 66 | cellular response to interleukin-15 (GO:0071350) | 3.26719243 |
| 67 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.24446943 |
| 68 | type I interferon signaling pathway (GO:0060337) | 3.23983019 |
| 69 | cellular response to type I interferon (GO:0071357) | 3.23983019 |
| 70 | regulation of T cell tolerance induction (GO:0002664) | 3.23756005 |
| 71 | B cell mediated immunity (GO:0019724) | 3.22081424 |
| 72 | response to type I interferon (GO:0034340) | 3.21082273 |
| 73 | regulation of tolerance induction (GO:0002643) | 3.20902875 |
| 74 | negative regulation of interleukin-6 production (GO:0032715) | 3.20199066 |
| 75 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.14965194 |
| 76 | myeloid leukocyte mediated immunity (GO:0002444) | 3.14792586 |
| 77 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.14227411 |
| 78 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.13003065 |
| 79 | response to muramyl dipeptide (GO:0032495) | 3.12729119 |
| 80 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.12000551 |
| 81 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.11991430 |
| 82 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.11458070 |
| 83 | defense response to protozoan (GO:0042832) | 3.07780974 |
| 84 | myeloid leukocyte activation (GO:0002274) | 3.07741012 |
| 85 | B cell receptor signaling pathway (GO:0050853) | 3.06686295 |
| 86 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.05503988 |
| 87 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.04400581 |
| 88 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.00701103 |
| 89 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.00701103 |
| 90 | germinal center formation (GO:0002467) | 2.97320331 |
| 91 | granulocyte chemotaxis (GO:0071621) | 2.97212618 |
| 92 | regulation of B cell differentiation (GO:0045577) | 2.97012920 |
| 93 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.96981232 |
| 94 | negative regulation of innate immune response (GO:0045824) | 2.90938530 |
| 95 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.90661452 |
| 96 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.90156931 |
| 97 | superoxide anion generation (GO:0042554) | 2.88956618 |
| 98 | dendritic cell migration (GO:0036336) | 2.88538633 |
| 99 | granulocyte migration (GO:0097530) | 2.88472136 |
| 100 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.88364491 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.01760110 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.61907132 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.39061372 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.83762169 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.33953201 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.28812712 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.27948274 |
| 8 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.96689927 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.95664256 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.89730766 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.81313760 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.77752606 |
| 13 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.76838778 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.73660202 |
| 15 | SPI1_23127762_ChIP-Seq_K562_Human | 2.68274260 |
| 16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.66514106 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.55018719 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.52116504 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.49914300 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.40681771 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.35900247 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 2.34501154 |
| 23 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.30570123 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.23277707 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.13837484 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 2.13382557 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.12662311 |
| 28 | * MYB_26560356_Chip-Seq_TH2_Human | 2.07394747 |
| 29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.03131283 |
| 30 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00997863 |
| 31 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.95440725 |
| 32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.94647982 |
| 33 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.94595395 |
| 34 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.89905039 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.85633311 |
| 36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.85584218 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.82336558 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.80488887 |
| 39 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.80123724 |
| 40 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.79007700 |
| 41 | * MYB_26560356_Chip-Seq_TH1_Human | 1.78710398 |
| 42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.77977687 |
| 43 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.69594428 |
| 44 | MAF_26560356_Chip-Seq_TH2_Human | 1.69569732 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.66162074 |
| 46 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.63604010 |
| 47 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.61109945 |
| 48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59453115 |
| 49 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.58552903 |
| 50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.54587109 |
| 51 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.54023049 |
| 52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53853440 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.52905306 |
| 54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.52335776 |
| 55 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.52223515 |
| 56 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.50557550 |
| 57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.50491514 |
| 58 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45675197 |
| 59 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.45128744 |
| 60 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.42184332 |
| 61 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.38149620 |
| 62 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38049850 |
| 63 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36912528 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35301356 |
| 65 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.33533137 |
| 66 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31196619 |
| 67 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31100078 |
| 68 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.28583526 |
| 69 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.28138741 |
| 70 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27276610 |
| 71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26459976 |
| 72 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.23181918 |
| 73 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.21756658 |
| 74 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.21527451 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17731839 |
| 76 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17048893 |
| 77 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.16383900 |
| 78 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15812890 |
| 79 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13924961 |
| 80 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12214622 |
| 81 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11723438 |
| 82 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11603006 |
| 83 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11585009 |
| 84 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.07606594 |
| 85 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07525042 |
| 86 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07236658 |
| 87 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06067127 |
| 88 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03361764 |
| 89 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01543860 |
| 90 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95900656 |
| 91 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95883079 |
| 92 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95227779 |
| 93 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.94344231 |
| 94 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91836406 |
| 95 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91552361 |
| 96 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90254103 |
| 97 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88427980 |
| 98 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.88038235 |
| 99 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.84777146 |
| 100 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.82274895 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.27971365 |
| 2 | MP0003436_decreased_susceptibility_to | 4.49384463 |
| 3 | MP0003303_peritoneal_inflammation | 3.83168867 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.53596876 |
| 5 | MP0002419_abnormal_innate_immunity | 3.49924081 |
| 6 | MP0009785_altered_susceptibility_to | 3.33461320 |
| 7 | MP0005025_abnormal_response_to | 3.12406317 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 2.87091226 |
| 9 | MP0001790_abnormal_immune_system | 2.84660947 |
| 10 | MP0005387_immune_system_phenotype | 2.84660947 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.84364509 |
| 12 | MP0006082_CNS_inflammation | 2.82978948 |
| 13 | MP0005671_abnormal_response_to | 2.76127071 |
| 14 | MP0001800_abnormal_humoral_immune | 2.73507618 |
| 15 | MP0000685_abnormal_immune_system | 2.68833894 |
| 16 | MP0002723_abnormal_immune_serum | 2.55303904 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.52340134 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.49865453 |
| 19 | MP0001819_abnormal_immune_cell | 2.49412823 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.44907700 |
| 21 | MP0008260_abnormal_autophagy | 2.44785426 |
| 22 | MP0001533_abnormal_skeleton_physiology | 2.37708491 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.35482047 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.12934373 |
| 25 | MP0002405_respiratory_system_inflammati | 1.99993703 |
| 26 | MP0003172_abnormal_lysosome_physiology | 1.90814989 |
| 27 | MP0001845_abnormal_inflammatory_respons | 1.86786067 |
| 28 | MP0003828_pulmonary_edema | 1.83451963 |
| 29 | MP0002132_abnormal_respiratory_system | 1.83338203 |
| 30 | MP0000716_abnormal_immune_system | 1.80191659 |
| 31 | MP0002398_abnormal_bone_marrow | 1.78268906 |
| 32 | MP0009278_abnormal_bone_marrow | 1.73686482 |
| 33 | MP0004947_skin_inflammation | 1.70358421 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.70014300 |
| 35 | MP0003763_abnormal_thymus_physiology | 1.69078486 |
| 36 | MP0002277_abnormal_respiratory_mucosa | 1.64482734 |
| 37 | MP0008469_abnormal_protein_level | 1.53356082 |
| 38 | MP0003183_abnormal_peptide_metabolism | 1.53217586 |
| 39 | MP0009764_decreased_sensitivity_to | 1.51321605 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.51277688 |
| 41 | MP0002396_abnormal_hematopoietic_system | 1.50297643 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.48063369 |
| 43 | MP0002722_abnormal_immune_system | 1.47961088 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.47654765 |
| 45 | MP0004883_abnormal_blood_vessel | 1.45323864 |
| 46 | MP0003806_abnormal_nucleotide_metabolis | 1.44783449 |
| 47 | MP0002429_abnormal_blood_cell | 1.42346320 |
| 48 | MP0005058_abnormal_lysosome_morphology | 1.41788517 |
| 49 | MP0004381_abnormal_hair_follicle | 1.41350868 |
| 50 | MP0000858_altered_metastatic_potential | 1.40632101 |
| 51 | MP0001851_eye_inflammation | 1.39584152 |
| 52 | MP0003075_altered_response_to | 1.38444807 |
| 53 | MP0003866_abnormal_defecation | 1.36189128 |
| 54 | MP0004510_myositis | 1.31894461 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.30307619 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.30307619 |
| 57 | MP0005310_abnormal_salivary_gland | 1.27246908 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.26136597 |
| 59 | MP0005164_abnormal_response_to | 1.25518718 |
| 60 | MP0005451_abnormal_body_composition | 1.22087311 |
| 61 | MP0000703_abnormal_thymus_morphology | 1.20747752 |
| 62 | MP0003690_abnormal_glial_cell | 1.16978026 |
| 63 | MP0000343_altered_response_to | 1.10214289 |
| 64 | MP0005166_decreased_susceptibility_to | 0.99254943 |
| 65 | MP0005390_skeleton_phenotype | 0.98582091 |
| 66 | MP0003448_altered_tumor_morphology | 0.90614377 |
| 67 | MP0009763_increased_sensitivity_to | 0.90167364 |
| 68 | MP0008004_abnormal_stomach_pH | 0.87004950 |
| 69 | MP0009840_abnormal_foam_cell | 0.85720566 |
| 70 | MP0000604_amyloidosis | 0.84566652 |
| 71 | MP0000490_abnormal_crypts_of | 0.79175582 |
| 72 | MP0001663_abnormal_digestive_system | 0.77335689 |
| 73 | MP0001853_heart_inflammation | 0.74221572 |
| 74 | MP0001958_emphysema | 0.74190346 |
| 75 | MP0003795_abnormal_bone_structure | 0.74133201 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 0.73439520 |
| 77 | MP0005075_abnormal_melanosome_morpholog | 0.72604284 |
| 78 | MP0005083_abnormal_biliary_tract | 0.72123839 |
| 79 | MP0003566_abnormal_cell_adhesion | 0.71511627 |
| 80 | MP0009765_abnormal_xenobiotic_induced | 0.69527946 |
| 81 | MP0003045_fibrosis | 0.68863333 |
| 82 | MP0008874_decreased_physiological_sensi | 0.66591550 |
| 83 | MP0001986_abnormal_taste_sensitivity | 0.66204174 |
| 84 | MP0002166_altered_tumor_susceptibility | 0.63754316 |
| 85 | MP0005319_abnormal_enzyme/_coenzyme | 0.62423747 |
| 86 | MP0002933_joint_inflammation | 0.61025966 |
| 87 | MP0000249_abnormal_blood_vessel | 0.59862378 |
| 88 | MP0004808_abnormal_hematopoietic_stem | 0.59778168 |
| 89 | MP0002138_abnormal_hepatobiliary_system | 0.56714410 |
| 90 | MP0001542_abnormal_bone_strength | 0.55510484 |
| 91 | MP0003221_abnormal_cardiomyocyte_apopto | 0.54674549 |
| 92 | MP0002133_abnormal_respiratory_system | 0.54202019 |
| 93 | MP0005388_respiratory_system_phenotype | 0.54202019 |
| 94 | MP0000015_abnormal_ear_pigmentation | 0.54112487 |
| 95 | MP0000920_abnormal_myelination | 0.53671029 |
| 96 | MP0004858_abnormal_nervous_system | 0.52409912 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.52243421 |
| 98 | MP0003091_abnormal_cell_migration | 0.52085451 |
| 99 | MP0003878_abnormal_ear_physiology | 0.51230633 |
| 100 | MP0005377_hearing/vestibular/ear_phenot | 0.51230633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 7.28981846 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.82151036 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.51578865 |
| 4 | Abnormality of macrophages (HP:0004311) | 6.21832882 |
| 5 | Myositis (HP:0100614) | 5.83024205 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.57150047 |
| 7 | Stomatitis (HP:0010280) | 5.38431566 |
| 8 | Orchitis (HP:0100796) | 5.37210503 |
| 9 | Optic neuritis (HP:0100653) | 4.98824731 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 4.98824731 |
| 11 | Chronic obstructive pulmonary disease (HP:0006510) | 4.44028371 |
| 12 | Obstructive lung disease (HP:0006536) | 4.44028371 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.37421354 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 4.33227272 |
| 15 | Gastrointestinal infarctions (HP:0005244) | 4.14826663 |
| 16 | Recurrent skin infections (HP:0001581) | 4.10054779 |
| 17 | Recurrent fungal infections (HP:0002841) | 4.02556334 |
| 18 | Meningitis (HP:0001287) | 3.93236025 |
| 19 | Gingivitis (HP:0000230) | 3.89162212 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.88777682 |
| 21 | Urticaria (HP:0001025) | 3.85103197 |
| 22 | Keratoconjunctivitis sicca (HP:0001097) | 3.74005072 |
| 23 | Hypochromic microcytic anemia (HP:0004840) | 3.61632619 |
| 24 | Increased IgE level (HP:0003212) | 3.51675246 |
| 25 | Encephalitis (HP:0002383) | 3.45177287 |
| 26 | Keratoconjunctivitis (HP:0001096) | 3.44594594 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.33090488 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.33090488 |
| 29 | Prolonged bleeding time (HP:0003010) | 3.32689320 |
| 30 | Spontaneous hematomas (HP:0007420) | 3.31197254 |
| 31 | Episodic fever (HP:0001954) | 3.26640906 |
| 32 | Cellulitis (HP:0100658) | 3.25219984 |
| 33 | Vasculitis (HP:0002633) | 3.22282599 |
| 34 | Hypochromic anemia (HP:0001931) | 3.13444343 |
| 35 | Petechiae (HP:0000967) | 3.08812429 |
| 36 | Anorexia (HP:0002039) | 2.98086929 |
| 37 | Gingival bleeding (HP:0000225) | 2.97356393 |
| 38 | Chest pain (HP:0100749) | 2.94345166 |
| 39 | Pulmonary infiltrates (HP:0002113) | 2.92334709 |
| 40 | Hemoptysis (HP:0002105) | 2.87422115 |
| 41 | Abnormality of glycolipid metabolism (HP:0010969) | 2.87258966 |
| 42 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.87258966 |
| 43 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.87258966 |
| 44 | Peritonitis (HP:0002586) | 2.84828501 |
| 45 | Pustule (HP:0200039) | 2.73620616 |
| 46 | Epistaxis (HP:0000421) | 2.70139043 |
| 47 | Amyloidosis (HP:0011034) | 2.65354578 |
| 48 | Osteomyelitis (HP:0002754) | 2.63792112 |
| 49 | Inflammation of the large intestine (HP:0002037) | 2.59758885 |
| 50 | Leukocytosis (HP:0001974) | 2.59456236 |
| 51 | T lymphocytopenia (HP:0005403) | 2.56135928 |
| 52 | Increased IgM level (HP:0003496) | 2.55462296 |
| 53 | Increased cerebral lipofuscin (HP:0011813) | 2.53898003 |
| 54 | Arterial thrombosis (HP:0004420) | 2.53339411 |
| 55 | Gastrointestinal inflammation (HP:0004386) | 2.50115043 |
| 56 | Abnormality of T cell number (HP:0011839) | 2.49030542 |
| 57 | Hepatosplenomegaly (HP:0001433) | 2.48051804 |
| 58 | Purpura (HP:0000979) | 2.46765144 |
| 59 | Sepsis (HP:0100806) | 2.42685643 |
| 60 | Recurrent viral infections (HP:0004429) | 2.42317295 |
| 61 | Pulmonary embolism (HP:0002204) | 2.40332494 |
| 62 | Premature loss of primary teeth (HP:0006323) | 2.39363333 |
| 63 | Loss of speech (HP:0002371) | 2.34427797 |
| 64 | Abnormality of T cells (HP:0002843) | 2.31479563 |
| 65 | Panhypogammaglobulinemia (HP:0003139) | 2.31009520 |
| 66 | Microcytic anemia (HP:0001935) | 2.28927016 |
| 67 | Increased serum ferritin (HP:0003281) | 2.27613700 |
| 68 | Granulocytopenia (HP:0001913) | 2.27603966 |
| 69 | Hypergammaglobulinemia (HP:0010702) | 2.27511777 |
| 70 | Gangrene (HP:0100758) | 2.23019582 |
| 71 | Disinhibition (HP:0000734) | 2.22862833 |
| 72 | Skin ulcer (HP:0200042) | 2.21407695 |
| 73 | Abnormality of the pleura (HP:0002103) | 2.18676253 |
| 74 | Abnormality of iron homeostasis (HP:0011031) | 2.15435447 |
| 75 | Lymphopenia (HP:0001888) | 2.14370471 |
| 76 | Abnormality of T cell physiology (HP:0011840) | 2.10576805 |
| 77 | Abnormality of the peritoneum (HP:0002585) | 2.09082638 |
| 78 | Metaphyseal cupping (HP:0003021) | 2.08304104 |
| 79 | Abnormal platelet volume (HP:0011876) | 2.06806507 |
| 80 | Interstitial pulmonary disease (HP:0006530) | 2.06451271 |
| 81 | Colitis (HP:0002583) | 2.04410872 |
| 82 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.04395980 |
| 83 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.99765729 |
| 84 | Abnormality of the pericardium (HP:0001697) | 1.98213892 |
| 85 | Slow saccadic eye movements (HP:0000514) | 1.97580183 |
| 86 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.96785815 |
| 87 | Abnormality of the endocardium (HP:0004306) | 1.95703779 |
| 88 | Difficulty running (HP:0009046) | 1.95088286 |
| 89 | Hypermelanotic macule (HP:0001034) | 1.95029440 |
| 90 | Acne (HP:0001061) | 1.94529492 |
| 91 | Recurrent pneumonia (HP:0006532) | 1.94200615 |
| 92 | Glomerulopathy (HP:0100820) | 1.93849905 |
| 93 | Vertigo (HP:0002321) | 1.92392433 |
| 94 | Keratitis (HP:0000491) | 1.88537663 |
| 95 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.85894145 |
| 96 | Cheilitis (HP:0100825) | 1.81889952 |
| 97 | Eosinophilia (HP:0001880) | 1.80934515 |
| 98 | Skin rash (HP:0000988) | 1.79493488 |
| 99 | Systemic lupus erythematosus (HP:0002725) | 1.79280588 |
| 100 | Pathologic fracture (HP:0002756) | 1.78396605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.41302057 |
| 2 | MAP2K3 | 3.58102430 |
| 3 | IRAK4 | 3.29895257 |
| 4 | BLK | 3.21485409 |
| 5 | MAP4K1 | 3.17867713 |
| 6 | ERN1 | 2.95698383 |
| 7 | CSK | 2.90499164 |
| 8 | FES | 2.70504155 |
| 9 | TYK2 | 2.68688606 |
| 10 | GRK6 | 2.47833578 |
| 11 | TNK2 | 2.38955546 |
| 12 | EPHB1 | 2.26806544 |
| 13 | MAP3K3 | 2.20510843 |
| 14 | FGR | 2.18465235 |
| 15 | ZAP70 | 2.15998841 |
| 16 | TAOK1 | 2.15474783 |
| 17 | PRPF4B | 2.03077195 |
| 18 | BTK | 1.84524164 |
| 19 | HCK | 1.82602686 |
| 20 | MAP3K11 | 1.72977980 |
| 21 | JAK3 | 1.67329052 |
| 22 | SYK | 1.63304320 |
| 23 | LYN | 1.45686259 |
| 24 | TXK | 1.39333044 |
| 25 | SIK3 | 1.38299332 |
| 26 | JAK2 | 1.36485721 |
| 27 | YES1 | 1.29670366 |
| 28 | KSR2 | 1.29317994 |
| 29 | TBK1 | 1.27668197 |
| 30 | MAP3K14 | 1.27087498 |
| 31 | MAP3K1 | 1.26827106 |
| 32 | MAP3K6 | 1.26108038 |
| 33 | IKBKE | 1.24218634 |
| 34 | CSF1R | 1.21842809 |
| 35 | JAK1 | 1.17259060 |
| 36 | TAOK2 | 1.16914387 |
| 37 | MAP3K13 | 1.15896064 |
| 38 | LCK | 1.13499790 |
| 39 | MARK3 | 1.06237062 |
| 40 | PRKD2 | 1.04866724 |
| 41 | PTK6 | 1.03962356 |
| 42 | MARK2 | 0.98888367 |
| 43 | TESK2 | 0.97012858 |
| 44 | ITK | 0.96667906 |
| 45 | KIT | 0.95406921 |
| 46 | STK10 | 0.94088991 |
| 47 | TEC | 0.92112892 |
| 48 | PDK1 | 0.88086567 |
| 49 | TGFBR2 | 0.87797010 |
| 50 | PDPK1 | 0.86405495 |
| 51 | MATK | 0.84857916 |
| 52 | TRIB3 | 0.81561990 |
| 53 | SIK2 | 0.79022497 |
| 54 | CDK19 | 0.78047574 |
| 55 | MAP2K4 | 0.76261778 |
| 56 | IRAK2 | 0.76182056 |
| 57 | FYN | 0.76078020 |
| 58 | PTK2B | 0.75965700 |
| 59 | IRAK1 | 0.74596450 |
| 60 | BMPR2 | 0.73544947 |
| 61 | TAOK3 | 0.73274837 |
| 62 | IKBKB | 0.73031283 |
| 63 | MAP3K5 | 0.72129516 |
| 64 | LRRK2 | 0.70729085 |
| 65 | SMG1 | 0.67275909 |
| 66 | SIK1 | 0.61502608 |
| 67 | MAP3K2 | 0.60446686 |
| 68 | CDC42BPA | 0.58571940 |
| 69 | MAPK12 | 0.56268971 |
| 70 | MAP2K6 | 0.55934560 |
| 71 | STK11 | 0.55920030 |
| 72 | STK38 | 0.54204562 |
| 73 | GRK7 | 0.53288680 |
| 74 | MAP3K7 | 0.52913109 |
| 75 | DYRK1B | 0.51846697 |
| 76 | RET | 0.49470033 |
| 77 | SGK3 | 0.48883106 |
| 78 | PIK3CG | 0.47537443 |
| 79 | RPS6KC1 | 0.47244848 |
| 80 | RPS6KL1 | 0.47244848 |
| 81 | PRKCQ | 0.46041764 |
| 82 | PRKG2 | 0.45170286 |
| 83 | RAF1 | 0.44956450 |
| 84 | EPHA3 | 0.44577366 |
| 85 | MAPKAPK2 | 0.43844565 |
| 86 | MAPK7 | 0.40933105 |
| 87 | MOS | 0.40482249 |
| 88 | DAPK2 | 0.39669084 |
| 89 | PRKCD | 0.39243706 |
| 90 | RPS6KA6 | 0.38495872 |
| 91 | BMX | 0.38045665 |
| 92 | KSR1 | 0.37965848 |
| 93 | HIPK2 | 0.34438454 |
| 94 | MAP3K8 | 0.33672543 |
| 95 | FGFR4 | 0.33460663 |
| 96 | PIM1 | 0.32983839 |
| 97 | ALK | 0.32811815 |
| 98 | PRKCZ | 0.31836034 |
| 99 | FGFR3 | 0.31535830 |
| 100 | ABL1 | 0.28063595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.32413910 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.24658272 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.06877016 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.98709586 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.32422721 |
| 6 | Tuberculosis_Homo sapiens_hsa05152 | 2.27841160 |
| 7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.21958124 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.14598565 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.11445170 |
| 10 | Malaria_Homo sapiens_hsa05144 | 2.07459928 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.07000091 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.99342009 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.99078614 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.89884354 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.77162557 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.76307580 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.70952509 |
| 18 | Phagosome_Homo sapiens_hsa04145 | 1.69872884 |
| 19 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.67630049 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.64431018 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.60286040 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.59976005 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.55930300 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.53215521 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.51617448 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.50632131 |
| 27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.48563625 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.45203346 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.41858178 |
| 30 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.38533144 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.37395877 |
| 32 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.34483357 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.31687769 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.31455033 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27274896 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.26861533 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.25390475 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.20902424 |
| 39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.19498038 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.18437843 |
| 41 | Lysosome_Homo sapiens_hsa04142 | 1.17743260 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 1.16737256 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 1.16397199 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 1.13622042 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.13028606 |
| 46 | Asthma_Homo sapiens_hsa05310 | 1.08339900 |
| 47 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.05205995 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 0.99158155 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 0.98166361 |
| 50 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.96160027 |
| 51 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96078207 |
| 52 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.91787844 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91441008 |
| 54 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.88291246 |
| 55 | Apoptosis_Homo sapiens_hsa04210 | 0.87792111 |
| 56 | Amoebiasis_Homo sapiens_hsa05146 | 0.84966145 |
| 57 | * Endocytosis_Homo sapiens_hsa04144 | 0.82718126 |
| 58 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.81812206 |
| 59 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.78817433 |
| 60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.77376173 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75533944 |
| 62 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75479352 |
| 63 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74532466 |
| 64 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74382611 |
| 65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72504871 |
| 66 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.71829948 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70998438 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70187010 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69723589 |
| 70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67034860 |
| 71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64036298 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63940671 |
| 73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63856856 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63455605 |
| 75 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.61541421 |
| 76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60866827 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60791226 |
| 78 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59581541 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56870476 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55935001 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55638616 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55421021 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54086103 |
| 84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52789410 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52653721 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49341678 |
| 87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48930479 |
| 88 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48095796 |
| 89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45849611 |
| 90 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42564230 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.41479172 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41248722 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41162705 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.40935477 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39489590 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39467195 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39370331 |
| 98 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38234288 |
| 99 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38188515 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35821195 |

